Lubricating fluid for orthokeratology lenses and orthokeratology lens product for preventing and treating myopia
A lubricant and atropine technology, applied in the field of eye health products, can solve problems such as limited vision improvement effect and corneal damage, and achieve the effects of increasing eye bioavailability, improving shaping effect, and making up for the lack of tear layer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0040] The following preparation process is used to prepare the compound drug lubricant and the single drug lubricant to compare the differences in safety and curative effect, namely:
[0041] 1. Weigh sodium hyaluronate, add 80% of the prescribed amount of water for injection (temperature 70°C), stir and mix well, then adjust the volume to replenish water to 100%, and stir and mix evenly to prepare a sodium hyaluronate containing 0.8% (w / v) in aqueous solution;
[0042] 2. After cooling the feed liquid obtained in step 1 to room temperature, add atropine sulfate to form an aqueous solution with a concentration of 0.01% (w / v);
[0043] 3. In step 2 gained solution, add osmotic pressure buffer sodium chloride successively (osmotic pressure is adjusted to be 300mOsm / L), acid-base regulator phosphate buffered saline system (regulating pH is 6.0);
[0044] After mixing evenly, stir well, according to the relevant requirements of the "Chinese Pharmacopoeia 2020 Edition (4)" eye d...
Embodiment 1
[0068] Weigh sodium hyaluronate, add 60% of the prescribed amount of water for injection (temperature 60°C), stir well and mix evenly, then adjust the volume to 100%, and make an aqueous solution containing 0.5% (w / v) sodium hyaluronate, stir Mix evenly; After the feed liquid is cooled to room temperature, add atropine sulfate and be made into the aqueous solution that concentration is 0.001% (w / v); Add sodium chloride in solution, adjust osmotic pressure to be 260mOsm / L, add phosphate buffer system, And adjust the pH to 5.5, after mixing evenly, fully stir, according to the relevant requirements of "Chinese Pharmacopoeia 2020 Edition (Four Parts)", filter through a 0.22 μm microporous membrane, sterilize, single-dose aseptic subpackaging, and pass the light inspection. Promptly obtain lubricating liquid, this lubricating liquid viscosity is 7mps.
Embodiment 2
[0070] Weigh sodium hyaluronate, add 90% of the prescribed amount of water for injection (temperature 90°C), stir well and mix evenly, then adjust the volume to 100%, and make an aqueous solution containing 1.5% (w / v) of sodium hyaluronate, stir Mix evenly; After the feed liquid is cooled to room temperature, add atropine sulfate and be made into the aqueous solution that concentration is 0.02% (w / v); Add boric acid in solution, regulate osmotic pressure to be 320mOsm / L, add citrate buffer system, and Adjust the pH to 6.0, after mixing evenly, stir fully, according to the relevant requirements of "Chinese Pharmacopoeia 2020 Edition (Four Parts)", filter through a 0.22 μm microporous membrane, sterilize, single-dose aseptically dispensed, and pass the light inspection, that is, Obtain lubricating fluid, and this lubricating fluid viscosity is 28mps.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com